Literature DB >> 2725700

Chloride-dependence of the potency of inhibitors of the neuronal noradrenaline carrier in the rat vas deferens.

A L Ungell1, H Oberleithner, K H Graefe.   

Abstract

(1) Vasa deferentia obtained from reserpine-pretreated rats were exposed to 0.15 mumol l-1 3H-(-)noradrenaline (with monoamine oxidase and catechol-O-methyltransferase being inhibited) and initial rates of the neuronal 3H-noradrenaline uptake as well as IC50 values for inhibition of uptake by desipramine, cocaine or (-)metaraminol determined at various external Cl- concentrations (0-145 mmol l-1) and a fixed high Na+ concentration (145 mmol l-1). (2) When the Cl- concentration in the medium was decreased neuronal uptake fell. As far as Cl- concentrations ranging from 10 to 145 mmol l-1 are concerned, the dependence of uptake on Cl- obeyed Michaelis-Menten kinetics with an apparent Km and Vmax of 6.2 mmol l-1 and 116 pmol g-1 min-1, respectively. At Cl- concentrations below 10 mmol l-1, uptake was higher than expected from the values of Km and Vmax, and even in the nominal absence of Cl- from the medium a remainder of neuronal uptake was still detectable. Evidence is presented to show that, on incubation at Cl- concentrations below 10 mmol l-1, intracellular Cl- leaks out, so that the actual Cl- concentrations in the extracellular fluid are probably higher than in the medium. (3) The potencies of desipramine and cocaine for inhibition of neuronal uptake were markedly dependent on the Cl- concentration in the medium, but the type of Cl- -dependence differed. While the IC50 for desipramine decreased, that for cocaine increased with increasing Cl- concentration (2-145 mmol l-1).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2725700     DOI: 10.1007/bf00165128

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  15 in total

1.  Statistical estimations in enzyme kinetics.

Authors:  G N WILKINSON
Journal:  Biochem J       Date:  1961-08       Impact factor: 3.857

2.  A major role for chloride in (3H)- noradrenaline transport by rat heart adrenergic nerves.

Authors:  S Sánchez-Armáss; F Orrego
Journal:  Life Sci       Date:  1977-06-01       Impact factor: 5.037

3.  Studies in vitro of amine uptake mechanisms in heart.

Authors:  A Giachetti; P A Shore
Journal:  Biochem Pharmacol       Date:  1966-05       Impact factor: 5.858

4.  Kinetic analysis of the interaction between noradrenaline and Na+ in neuronal uptake: kinetic evidence for CO-transport.

Authors:  S Sammet; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-11       Impact factor: 3.000

5.  Solubilization and characterization of the 3H-desipramine binding site of rat phaeochromocytoma cells (PC12-cells).

Authors:  E Schömig; H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-12       Impact factor: 3.000

6.  Sodium dependence of transmitter uptake at adrenergic nerve terminals.

Authors:  L L Iversen; E A Kravitz
Journal:  Mol Pharmacol       Date:  1966-07       Impact factor: 4.436

7.  Characterization of [3H]desipramine binding associated with neuronal norepinephrine uptake sites in rat brain membranes.

Authors:  C M Lee; J A Javitch; S H Snyder
Journal:  J Neurosci       Date:  1982-10       Impact factor: 6.167

8.  Measurement of intracellular chloride in guinea-pig vas deferens by ion analysis, 36chloride efflux and micro-electrodes.

Authors:  C C Aickin; A F Brading
Journal:  J Physiol       Date:  1982-05       Impact factor: 5.182

9.  Sodium-dependence of the potency of inhibitors of the neuronal noradrenaline carrier in the rat vas deferens.

Authors:  C J Zeitner; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-12       Impact factor: 3.000

10.  Binding of 3H-desipramine to the neuronal noradrenaline carrier of rat phaeochromocytoma cells (PC-12 cells).

Authors:  H Bönisch; R Harder
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-12       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.